Research progress on the role of FGF21 in insulin resistance
The elevated global prevalence of metabolic syndrome and type 2 diabetes mellitus (T2DM) has led to a dramatic increase in patients with insulin resistance. The majority of insulin resistance is closely associated with obesity and metabolic syndrome, resulting in impaired insulin signaling pathways....
Saved in:
| Main Authors: | Haixin Zhang, Rongyu Zhu, Quanhao Sun, Likun Du |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-08-01
|
| Series: | Frontiers in Endocrinology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2025.1619462/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
FGF21 gene therapy as treatment for obesity and insulin resistance
by: Veronica Jimenez, et al.
Published: (2018-07-01) -
Assessment of Insulin Resistance using the Glucose Tolerance Insulin Response (GTIR) Test and Homeostasis Model Assessment-Estimated Insulin Resistance (HOMA-IR) Test
by: Mona F. Kardus, et al.
Published: (2024-10-01) -
p21-activated kinases (PAKs) regulate FGF1/PDE4D antilipolytic pathway and insulin resistance in adipocytes
by: Judith Seigner, et al.
Published: (2025-09-01) -
The Effect of 12 Weeks of Resistance Training on Serum Levels of Myonectin and FGF-21 in Inactive Middle-aged Men
by: Zahra Yousefvand, et al.
Published: (2024-07-01) -
FGF21 and its underlying adipose tissue-liver axis inform cardiometabolic burden and improvement in obesity after metabolic surgeryResearch in context
by: Marie Patt, et al.
Published: (2024-12-01)